Besides FGF21 level, circulating levels of M30 and M65ED in patients with NAFLD were also significantly higher than those in non-NAFLD subjects after adjustment for age, gender and BMI (all P < 0.01). The gene discussed is FGF21; the disease is metabolic dysfunction-associated steatotic liver disease.